Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.

Ozturk K, Gencturk M, Caicedo-Granados E, Li F, Cayci Z.

AJR Am J Roentgenol. 2018 Oct 9:1-7. doi: 10.2214/AJR.18.19501. [Epub ahead of print]

PMID:
30300005
2.

Pretreatment quantitative 18F-FDG PET/CT parameters as a predictor of survival in adenoid cystic carcinoma of the salivary glands.

Gencturk M, Ozturk K, Koksel Y, Li F, Cayci Z.

Clin Imaging. 2018 Oct 4;53:17-24. doi: 10.1016/j.clinimag.2018.09.021. [Epub ahead of print]

PMID:
30308429
3.

Relationship between 18FDG-PET and different types of sinonasal malignancies.

Felix-Ravelo M, Bey A, Arous F, Paris-Grandpierre S, Jankowski R, Nguyen DT.

Acta Otolaryngol. 2017 Feb;137(2):191-195. doi: 10.1080/00016489.2016.1219917. Epub 2016 Aug 31.

PMID:
27576899
4.

Role of 18 F-FDG PET/CT differentiating olfactory neuroblastoma from sinonasal undifferentiated carcinoma.

Elkhatib AH, Soldatova L, Carrau RL, Hachem RA, Ditzel L, Campbell R, Prevedello DM, Prevedello L, Filho LF, Campbell RG.

Laryngoscope. 2017 Feb;127(2):321-324. doi: 10.1002/lary.26194. Epub 2016 Aug 2.

PMID:
27481043
5.

Comparison of standardized uptake values in normal structures between PET/CT and PET/MRI in an oncology patient population.

Kershah S, Partovi S, Traughber BJ, Muzic RF Jr, Schluchter MD, O'Donnell JK, Faulhaber P.

Mol Imaging Biol. 2013 Dec;15(6):776-85. doi: 10.1007/s11307-013-0629-8.

6.

Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.

Heusch P, Buchbender C, Beiderwellen K, Nensa F, Hartung-Knemeyer V, Lauenstein TC, Bockisch A, Forsting M, Antoch G, Heusner TA.

Eur J Radiol. 2013 May;82(5):870-6. doi: 10.1016/j.ejrad.2013.01.008. Epub 2013 Feb 8.

PMID:
23394765
7.

Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.

Jeong Y, Baek S, Park JW, Joo JH, Kim JS, Lee SW.

Br J Radiol. 2017 Mar;90(1071):20160239. doi: 10.1259/bjr.20160239. Epub 2016 Dec 23.

8.

Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.

Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.

Rofo. 2013 Nov;185(11):1056-62. doi: 10.1055/s-0033-1350110. Epub 2013 Jul 16.

9.

Semiquantitative Assessment of 18F-FDG Uptake in the Normal Skeleton: Comparison Between PET/CT and Time-of-Flight Simultaneous PET/MRI.

Minamimoto R, Xu G, Jamali M, Holley D, Barkhodari A, Zaharchuk G, Iagaru A.

AJR Am J Roentgenol. 2017 Nov;209(5):1136-1142. doi: 10.2214/AJR.17.18044. Epub 2017 Aug 4.

PMID:
28777652
10.

Correlation between standardized uptake value and apparent diffusion coefficient of neoplastic lesions evaluated with whole-body simultaneous hybrid PET/MRI.

Rakheja R, Chandarana H, DeMello L, Jackson K, Geppert C, Faul D, Glielmi C, Friedman KP.

AJR Am J Roentgenol. 2013 Nov;201(5):1115-9. doi: 10.2214/AJR.13.11304.

PMID:
24147485
11.

Multifunctional profiling of non-small cell lung cancer using 18F-FDG PET/CT and volume perfusion CT.

Sauter AW, Winterstein S, Spira D, Hetzel J, Schulze M, Mueller M, Pfannenberg C, Claussen CD, Klotz E, Hann von Weyhern C, Horger MS.

J Nucl Med. 2012 Apr;53(4):521-9. doi: 10.2967/jnumed.111.097865. Epub 2012 Mar 13.

12.

Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.

Lin CY, Liao CW, Chu LY, Yen KY, Jeng LB, Hsu CN, Lin CL, Kao CH.

Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.

PMID:
28114226
13.

Influence of scan time point and volume of intravenous contrast administration on blood-pool and liver SUVmax and SUVmean in [18F] FDG PET/CT.

Schoen M, Braun T, Manava P, Ludwigs S, Lell M.

Nuklearmedizin. 2018 Apr;57(2):50-55. doi: 10.3413/Nukmed-0919-17-08. Epub 2018 Mar 28.

PMID:
29590675
14.

[Primary tumor SUVmax measured on (18)F-FDG PET-CT correlates with histologic grade and pathologic stage in non-small cell lung cancer].

Zhao SJ, Wu N, Zheng R, Liu Y, Zhang WJ, Liang Y, Zhang H, Li XM.

Zhonghua Zhong Liu Za Zhi. 2013 Oct;35(10):754-7. Chinese.

PMID:
24378097
15.

Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors.

Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, Weber WA.

J Nucl Med. 2008 Jul;49(7):1038-46. doi: 10.2967/jnumed.107.050187. Epub 2008 Jun 13.

16.

Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.

Kitao T, Shiga T, Hirata K, Sekizawa M, Takei T, Yamashiro K, Tamaki N.

Ann Nucl Med. 2018 Sep 8. doi: 10.1007/s12149-018-1298-0. [Epub ahead of print]

PMID:
30196378
17.

Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.

Kim JW, Oh JS, Roh JL, Kim JS, Choi SH, Nam SY, Kim SY.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1353-61. doi: 10.1007/s00259-015-3051-4. Epub 2015 Jun 12.

PMID:
26067088
18.

(18)F-FDG PET/CT mean SUV and metabolic tumor volume for mean survival time in non-small cell lung cancer.

Kurtipek E, Çayci M, Düzgün N, Esme H, Terzi Y, Bakdik S, Aygün MS, Unlü Y, Burnik C, Bekci TT.

Clin Nucl Med. 2015 Jun;40(6):459-63. doi: 10.1097/RLU.0000000000000740.

PMID:
25742234
19.

Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas.

Benz MR, Allen-Auerbach MS, Eilber FC, Chen HJ, Dry S, Phelps ME, Czernin J, Weber WA.

J Nucl Med. 2008 Oct;49(10):1579-84. doi: 10.2967/jnumed.108.053694. Epub 2008 Sep 15.

20.

Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.

Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.

Biomed Mater Eng. 2014;24(6):3091-103. doi: 10.3233/BME-141131.

PMID:
25227018

Supplemental Content

Support Center